Literature DB >> 16636595

Decreased expression of aquaporin water channels in denervated rat kidney.

JongUn Lee1, Kwangjay Yoo, Soo Wan Kim, Kyoon Ho Jung, Seong Kwon Ma, Yeon Kyung Lee, Wan-Young Kim, Jin Kim, Ki Chul Choi.   

Abstract

AIMS: A neural mechanism regulating aquaporin (AQP) water channels in the kidney was investigated.
METHODS: Male Sprague-Dawley rats were used. Renal denervation was induced by painting the renal vessels with 10% phenol. The expression of AQP1-4 proteins was determined in the denervated and contralateral kidneys. The expression was also examined in rats which were renally denervated and subjected to water restriction or deoxycorticosterone acetate (DOCA)-salt treatment.
RESULTS: Following the unilateral denervation, tissue contents of norepinephrine were significantly decreased in the denervated kidney, while increased in the contralateral kidney. Accordingly, the expression of AQP1-4 proteins was decreased by 15-40% in the denervated kidney, and increased by 30-50% in the contralateral kidney. Immunohistochemistry of AQP2 confirmed its decreases in the denervated kidney and increases in the contralateral kidney. In bilaterally denervated rats, the urine flow increased along with decreased osmolarity. The water restriction increased the expression of AQP channels, however, the magnitude of which was lower in the denervated than in the contralateral kidney. Renal denervation decreased the degree of DOCA-salt hypertension, along with lower expression of AQP channels.
CONCLUSION: It is suggested that the sympathetic nerve should play a specific excitatory role in the regulation of AQP channels in the kidney. Copyright 2006 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16636595     DOI: 10.1159/000092918

Source DB:  PubMed          Journal:  Nephron Physiol        ISSN: 1660-2137


  8 in total

1.  Sex-dependent expression of water channel AQP1 along the rat nephron.

Authors:  Carol M Herak-Kramberger; Davorka Breljak; Marija Ljubojević; Mirela Matokanović; Mila Lovrić; Dunja Rogić; Hrvoje Brzica; Ivana Vrhovac; Dean Karaica; Vedran Micek; Jana Ivković Dupor; Dennis Brown; Ivan Sabolić
Journal:  Am J Physiol Renal Physiol       Date:  2015-02-04

2.  Effect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertension.

Authors:  Frank H Mose; Janni M Jensen; Safa Therwani; Jesper Mortensen; Annebirthe B Hansen; Jesper N Bech; Erling B Pedersen
Journal:  Br J Clin Pharmacol       Date:  2015-06-05       Impact factor: 4.335

3.  Abnormal function of the vasopressin-cyclic-AMP-aquaporin2 axis during urine concentrating and diluting in patients with reduced renal function. A case control study.

Authors:  Erling B Pedersen; Ingrid M Thomsen; Thomas G Lauridsen
Journal:  BMC Nephrol       Date:  2010-10-05       Impact factor: 2.388

4.  Water and sodium regulation in heart failure.

Authors:  Eun Hui Bae; Seong Kwon Ma
Journal:  Electrolyte Blood Press       Date:  2009-12-31

Review 5.  Nitric oxide in the kidney : its physiological role and pathophysiological implications.

Authors:  Jongun Lee
Journal:  Electrolyte Blood Press       Date:  2008-06-30

6.  Increased renal sodium absorption by inhibition of prostaglandin synthesis during fasting in healthy man. A possible role of the epithelial sodium channels.

Authors:  Thomas G Lauridsen; Henrik Vase; Jørn Starklint; Carolina C Graffe; Jesper N Bech; Søren Nielsen; Erling B Pedersen
Journal:  BMC Nephrol       Date:  2010-10-28       Impact factor: 2.388

7.  Effect of vasopressin antagonism on renal handling of sodium and water and central and brachial blood pressure during inhibition of the nitric oxide system in healthy subjects.

Authors:  Safa Al Therwani; Frank Holden Mose; Janni Majgaard Jensen; Jesper Nørgaard Bech; Erling Bjerregaard Pedersen
Journal:  BMC Nephrol       Date:  2014-06-25       Impact factor: 2.388

8.  Urine concentration ability is reduced to the same degree in adult dominant polycystic kidney disease compared with other chronic kidney diseases in the same CKD-stage and lower THAN in healthy control subjects - a CASE control study.

Authors:  M H Malmberg; F H Mose; E B Pedersen; J N Bech
Journal:  BMC Nephrol       Date:  2020-08-31       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.